• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膀胱癌整体光动力疗法的临床经验

Clinical experience with the integral photodynamic therapy of bladder carcinoma.

作者信息

Jocham D, Baumgartner R, Stepp H, Unsöld E

机构信息

Urologische Klinik und Poliklinik, Ludwig-Maximilians-Universität München, F.R.G.

出版信息

J Photochem Photobiol B. 1990 Jun;6(1-2):183-7. doi: 10.1016/1011-1344(90)85088-e.

DOI:10.1016/1011-1344(90)85088-e
PMID:2146378
Abstract

Photodynamic therapy (PDT) was given to 20 patients who had recurring superficial tumours after unsuccessful application of other treatments. The phototherapeutic results were evaluated by check-ups at 3 month intervals (endoscopy, cytology, bladder mapping, renal ultrasonography) and computed tomography (CT) examination at 8-13 month intervals. In six patients treated with PDT no tumour recurrence was found over the whole observation period up to nearly 5 years. Four patients remained free of tumour (12 and 14 months) after repeated transurethral resection (TUR) and Nd:YAG laser therapy following PDT. Due to an initial application of insufficient irradiation, four patients required a second photodynamic treatment. In one of these cases a circumscribed dysplasia which appeared at the left ostium 26 months following PDT was treated successfully using the Nd:YAG laser following TUR. In six patients slight mucosal atypia persisted for a period of at least 2.5 years. One cystectomy had to be performed because of bladder shrinkage. The dissected bladder was free of tumour. According to these preliminary results, PDT with strict patient selection (worst case situation with recommended cystectomy) is justified in the case of recurrent superficial TIS bladder carcinoma.

摘要

对20例经其他治疗失败后出现复发性浅表肿瘤的患者进行了光动力疗法(PDT)。通过每3个月进行一次检查(内镜检查、细胞学检查、膀胱造影、肾脏超声检查)以及每8 - 13个月进行一次计算机断层扫描(CT)检查来评估光疗效果。在接受PDT治疗的6例患者中,在长达近5年的整个观察期内均未发现肿瘤复发。4例患者在PDT后接受重复经尿道切除术(TUR)和钕钇铝石榴石(Nd:YAG)激光治疗后,肿瘤未复发(分别为12个月和14个月)。由于最初照射剂量不足,4例患者需要进行第二次光动力治疗。其中1例患者在PDT后26个月时,在左侧开口处出现局限性发育异常,在TUR后使用Nd:YAG激光成功治疗。6例患者的轻微黏膜异型性持续至少2.5年。因膀胱萎缩不得不进行1例膀胱切除术。切除的膀胱未发现肿瘤。根据这些初步结果,对于复发性浅表性Tis膀胱癌,在严格选择患者(推荐膀胱切除术的最坏情况)的情况下,PDT是合理的。

相似文献

1
Clinical experience with the integral photodynamic therapy of bladder carcinoma.膀胱癌整体光动力疗法的临床经验
J Photochem Photobiol B. 1990 Jun;6(1-2):183-7. doi: 10.1016/1011-1344(90)85088-e.
2
Long-term experience with integral photodynamic therapy of TIS bladder carcinoma.Tis期膀胱癌完整光动力疗法的长期经验。
Ciba Found Symp. 1989;146:198-205; discussion 205-8. doi: 10.1002/9780470513842.ch14.
3
[Photodynamic therapy of superficial bladder cancer. An alternative to radical cystectomy?].[浅表性膀胱癌的光动力疗法。根治性膀胱切除术的替代方法?]
Urologe A. 1994 Jul;33(4):276-80.
4
Whole bladder photodynamic therapy for transitional cell carcinoma of bladder.
Urology. 1985 Sep;26(3):274-80. doi: 10.1016/0090-4295(85)90125-6.
5
[Photodynamic therapy with hematoporphyrin derivative for transitional-cell carcinoma of the urinary bladder--report of 30 cases].[血卟啉衍生物光动力疗法治疗膀胱移行细胞癌——附30例报告]
Zhonghua Zhong Liu Za Zhi. 1989 Jul;11(4):304-6.
6
[Treatment of bladder cancer by Nd:YAG laser local irradiation and whole-bladder photodynamic therapy with hematoporphyrin derivative].
Zhonghua Zhong Liu Za Zhi. 1994 Nov;16(6):458-60.
7
Photodynamic therapy.光动力疗法
Urol Clin North Am. 1992 Aug;19(3):591-9.
8
Laser photodynamic therapy for bladder cancer.
Mayo Clin Proc. 1986 Nov;61(11):859-64. doi: 10.1016/s0025-6196(12)62606-8.
9
Photodynamic therapy using porfimer sodium as an alternative to cystectomy in patients with refractory transitional cell carcinoma in situ of the bladder. Bladder Photofrin Study Group.使用卟吩姆钠的光动力疗法作为膀胱原位难治性移行细胞癌患者膀胱切除术的替代方法。膀胱光卟啉研究组。
J Urol. 1998 Jul;160(1):39-44.
10
Integral laser-photodynamic treatment of multifocal bladder carcinoma photosensitized by hematoporphyrin derivative.血卟啉衍生物光敏化的多灶性膀胱癌的整体激光光动力治疗
Eur Urol. 1986;12 Suppl 1:43-6. doi: 10.1159/000472699.

引用本文的文献

1
Stable triangle: nanomedicine-based synergistic application of phototherapy and immunotherapy for tumor treatment.稳定三角:基于纳米医学的光疗和免疫疗法协同应用于肿瘤治疗。
J Nanobiotechnology. 2024 Oct 18;22(1):635. doi: 10.1186/s12951-024-02925-3.
2
Revisiting photodynamic therapy dosimetry: reductionist & surrogate approaches to facilitate clinical success.重新审视光动力疗法剂量测定法:采用简化论和替代方法以促进临床成功。
Phys Med Biol. 2016 Apr 7;61(7):R57-89. doi: 10.1088/0031-9155/61/7/R57. Epub 2016 Mar 10.
3
Imaging and photodynamic therapy: mechanisms, monitoring, and optimization.
成像与光动力疗法:作用机制、监测与优化
Chem Rev. 2010 May 12;110(5):2795-838. doi: 10.1021/cr900300p.
4
Photodynamic therapy: a new approach to prostate cancer.光动力疗法:前列腺癌的一种新疗法。
Curr Urol Rep. 2003 Jun;4(3):221-8. doi: 10.1007/s11934-003-0073-4.
5
Transient absorption changes in vivo during photodynamic therapy with pulsed-laser light.脉冲激光光动力治疗期间体内的瞬态吸收变化。
Br J Cancer. 1999 May;80(3-4):344-51. doi: 10.1038/sj.bjc.6690361.
6
Aminolevulinic acid for photodynamic therapy of bladder carcinoma cells.用于膀胱癌细胞光动力治疗的氨基乙酰丙酸
Urol Res. 1996;24(5):285-9. doi: 10.1007/BF00304778.
7
Comparison of two routes of photosensitizer administration for photodynamic therapy of bladder cancer.膀胱癌光动力治疗中两种光敏剂给药途径的比较。
Urol Res. 1994;22(1):21-3. doi: 10.1007/BF00431544.
8
Photodynamic efficiency of liposome-administered tetramethyl hematoporphyrin in two human bladder cancer cell lines.脂质体给药的四甲基血卟啉在两种人膀胱癌细胞系中的光动力效率
Urol Res. 1995;23(3):151-6. doi: 10.1007/BF00389566.